NATROX® Wound Care Logo

Committed to Advanced Wound Care Treatment

Delivering wound care technology that works seamlessly across the care continuum and that can transform patients’ lives.

We deliver advanced solutions to aid wound healing—even in chronic, non-healing wounds. Our innovative online platform makes it easier for healthcare professionals to manage wounds.

Read more about NATROX® O₂

Topical Oxygen Therapy (TOT) Evidence Continues to Grow

Increasing number of international guidelines and experts recommend use of cTOT

Stay Informed of Global Expert Recommendations

Explore the latest global endorsements and experts affirming the effectiveness of Continuous Topical Oxygen Therapy (cTOT). Discover why healthcare professionals worldwide are turning to NATROX® O₂ for chronic wound care. Delve into the comprehensive clinical evidence supporting this revolutionary approach.

Your path to informed, evidence-based wound care starts here.

See Clinical Evidence

Chronic Wounds:
The silent epidemic

Chronic wounds, or wounds that are slow to heal, affect millions of people worldwide, representing a burden for healthcare systems, society, and patients. It’s time to fight the silent epidemic.

Did you know 18% of global wounds are considered chronic?1 Costs to care for these wounds account for 60% of total wound care costs. But there are hidden costs, too.

See the hidden costs of wound care

Global burden from chronic wounds on the healthcare system:


more GP visits2


more hospital admissions2


more nurse practitioner visits2

Our Approach to Topical Oxygen Therapy

Our technology is designed to help those enduring and those treating chronic wounds.

Clinical Evidence, News, & Resources

New Expert Consensus: Topical Oxygen Therapy in Wound Healing

August 18, 2023

Consensus on the Clinical Efficacy and Guidelines of Continuous Topical Oxygen Therapy for Wounds – JoWC LATAM Oct 2023

November 02, 2023

New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy (TOT) for Diabetic Foot Ulcers

May 16, 2023

New Expert Opinion in Support of Topical Oxygen Therapy (TOT)

November 21, 2022

Delphi Consensus on Guidelines for the Use of Topical Oxygen

November 07, 2022

Health Technology Wales Guidance Advises Routine Adoption of NATROX® O₂

December 13, 2022

NATROX® O₂ Topical Oxygen Therapy: Master Evidence Summary & Clinical Insights

February 16, 2024

Supporting the Patient Journey – Podiatry Management Nov 2023

November 07, 2023

Podcast: Pain and the Journey of the Chronic Wound Patient

November 07, 2023

Holistic Approach to a Wound Care Patient

November 01, 2023

Supporting the Patient Journey: The Use of Topical Oxygen Therapy in Chronic Wound Pain Management

October 10, 2023

Accelerated Healing with NATROX® O₂: Managing Late Radiation Tissue Injury Following Mohs Surgery

January 09, 2024

The Efficacy of Continuous Topical Oxygen Therapy in the Treatment of Challenging Diabetic Foot Ulcers; A Case Series

November 01, 2023

Case Series Examining the Efficacy of cTOT in Treatment of DFUs

May 23, 2023

NATROX® O₂ Masterclass Guide

August 23, 2022

NATROX® Wound Care Ranks Number One for its Innovative Medical Technology

August 15, 2022

NATROX® O₂ Now Available in South Korea

August 17, 2023

Raise Healthcare Named UK Distributor for NATROX® Wound Care

April 27, 2023

Dr. Windy Cole, DPM Joins NATROX® Wound Care as Director of Global Medical Affairs

March 28, 2023

How wound care clinicians can optimize clinical outcomes and resources

October 10, 2022

Dr. Thomas Serena Joins NATROX® Wound Care Team as Chief Medical Officer

May 04, 2022

NATROX® Wound Care Appoints Eminent Wound Care and Biofilm Expert, Dr. Gregory Schultz, as Chief Scientific Officer

April 05, 2022

New NATROX® IQ Video Now Available

August 10, 2022

New Evidence in Support of Topical Oxygen Therapy (TOT)

July 06, 2022

NATROX® O₂ Masterclass Guide

August 23, 2022

PRHOINSA Appointed Exclusive Distributor in Spain for NATROX® Wound Care

July 13, 2022

New study shows substantial pain relief with NATROX® O₂

May 11, 2022

New Study Demonstrates Significantly Increased Healing Rates with NATROX® O₂

May 17, 2021

NATROX® O₂ Now Available Through NHS Supply Chain & NHS Shared Business Services

January 15, 2022

NATROX® O₂ Wins the “Best Wearable Tech in Health Care” Award

December 08, 2020

Connect to Learn More About NATROX® O₂

Complete this form to hear from our team. By using this form, you agree with our data storage and handling policy.

    Expand Reference List

    [1] Bionap, 2013. Seeking alpha [online] Available at: [Accessed 16 Jan 2020]

    [2] Guest, JF, et al, 2015. Health economic burden that wounds impose on the National Health Service in the UK: BMJ Open 2015:5:E009283. DOI:10.1136/BMJopen-2015-009283

    [3] Jones, N.C., G; Ivins, N.M.; Harding, K.G et al. (2017) The role of topical oxygen therapy in the treatment of diabetic foot ulceration. Poster in Wounds UK Harrogate, UK.

    [4] Serena TE, Bullock NM, Cole W et al. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled trial. J Wound Care 2021; 30: Suppl.5 S7-14